ReviewCardiovascular diabetology2021

Cardiovascular benefits of sodium-glucose cotransporter 2 inhibitors in diabetic and nondiabetic patients.

Boyang Xiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.